ReviewTherapeutic advances in hematology2015

CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL).

Sarah K Tasian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.